Wide spectrum modulation by KP-544 in models relevant for neuronal survival.
Neuroreport • Vol. 18, Issue 6 • 2007
The novel substituted pyrimidine, KP544, reduces motor deficits in the R6/2 transgenic mouse model of Huntington's disease.
Restorative neurology and neuroscience • Vol. 25, Issue 5-6 • 2007
Neurotrophic enhancers as therapy for behavioral deficits in rodent models of Huntington's disease: use of gangliosides, substituted pyrimidines, and mesenchymal stem cells.
Behavioral and cognitive neuroscience reviews • Vol. 5, Issue 2 • 2006